Detection of the Lipopeptide Pam3CSK4 Using a Hybridized Toll-like Receptor Electrochemical Sensor

被引:11
|
作者
She, Zhe [1 ,2 ]
Topping, Kristin [1 ]
Ma, Tianxiao [2 ]
Zhao, Tiantian [3 ]
Zhou, Wenxia [2 ]
Kamal, Ajar [2 ]
Ahmadi, Soha [2 ,4 ]
Kraatz, Heinz-Bernhard [1 ,2 ,4 ]
机构
[1] Royal Mil Coll Canada, Dept Chem & Chem Engn, POB 17000, Kingston, ON K7K 7B4, Canada
[2] Univ Toronto, Dept Phys & Environm Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada
[3] Univ Toronto, Dept Immunol, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada
[4] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
SURFACE-PLASMON RESONANCE; IMPEDANCE SPECTROSCOPY; TLR2; RECOGNITION; INNATE; HETERODIMERIZATION; SALMONELLA; ELECTRODES; BIOSENSOR; BACTERIA;
D O I
10.1021/acs.analchem.6b04799
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrochemical detection of Pam3CSK4, a synthetic triacylated lipopeptide that mimics the structural moieties of its natural Gram negative bacterial pathogen-associated molecular pattern (PAMP) counterpart, has been achieved using hybridized toll-like receptors (TLR) combining TLR1 and TLR2 onto a single sensor surface. These sensors represent the first hybridized TLR sensors. The limit of detection for Pam3CSK4 attained was 7.5 mu g/mL, which is within the same order of magnitude for that of the more labor-intensive and time-consuming cell-assay technique, 2.0 mu g/mL. The results gathered in these electrochemical experiments show that sensors fabricated by immobilizing a mixture of cooperative TLR1 and -2 generate higher responses when exposed to the analyte in comparison to the control sensors fabricated using pure TLR1 or -2 standalone. A PAMP selectivity test was carried out in line with our inspiration from the mammalian innate immune response. TLRs1-5 as standalone biorecognition elements and the hybridized "TLR1 and 2" sensor surface were investigated, understanding the known TLR-PAMP interactions, through the exploitation of this electrochemical sensor fabrication technique. The experimental result is consistent with observations from previously published in vivo and in vitro studies, and it is the first demonstration of the simultaneous evaluation of electrochemical responses from multiple, unique fabricated TLR sensor surfaces against the same analyte.
引用
收藏
页码:4882 / 4888
页数:7
相关论文
共 50 条
  • [1] Toll-Like Receptor 2 Agonist Pam3CSK4 Alleviates the Pathology of Leptospirosis in Hamster
    Zhang, Wenlong
    Zhang, Naisheng
    Xie, Xufeng
    Guo, Jian
    Jin, Xuemin
    Xue, Feng
    Ding, Zhuang
    Cao, Yongguo
    INFECTION AND IMMUNITY, 2016, 84 (12) : 3350 - 3357
  • [2] The toll-like receptor 2 agonist Pam3CSK4 is neuroprotective after spinal cord injury
    Stivers, Nicole S.
    Pelisch, Nicolas
    Orem, Ben C.
    Williams, Joshua
    Nally, Jacqueline M.
    Stirling, David P.
    EXPERIMENTAL NEUROLOGY, 2017, 294 : 1 - 11
  • [3] Effects of Toll-like receptor 1 and 2 agonist Pam3CSK4 on uveal melanocytes and relevant experimental mouse model
    Hu, Dan-Ning
    Zhang, Ruihua
    Iacob, Codrin E.
    Yao, Shen
    Yang, Shun-Fa
    Chan, Chi-Chao
    Rosen, Richard B.
    EXPERIMENTAL EYE RESEARCH, 2024, 239
  • [4] Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route
    Lombardi, V.
    Van Overtvelt, L.
    Horiot, S.
    Moussu, H.
    Chabre, H.
    Louise, A.
    Balazuc, A. -M.
    Mascarell, L.
    Moingeon, P.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2008, 38 (11): : 1819 - 1829
  • [5] Effect of the synthetic Toll-like receptor ligands LPS, Pam3CSK4, HKLM and FSL-1 in the function of bovine polymorphonuclear neutrophils
    Conejeros, Ivan
    Gibson, Amanda J.
    Werling, Dirk
    Munoz-Caro, Tamara
    Hermosilla, Carlos
    Taubert, Anja
    Burgos, Rafael A.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2015, 52 (02): : 215 - 225
  • [6] DIFFERENTIAL EFFECTS OF THE TOLL-LIKE RECEPTOR 2 AGONISTS, PGN AND Pam3CSK4, ON SUBSTANCE P-INDUCED HUMAN MAST CELL ACTIVATION
    Yu, Y. Y.
    Yip, K. H.
    Tam, I. Y. S.
    Sam, S. W.
    Ng, C. W.
    Lau, H. Y. A.
    EUROPEAN JOURNAL OF INFLAMMATION, 2013, 11 (03) : 709 - 718
  • [7] Differential Effects of the Toll-Like Receptor 2 Agonists, PGN and Pam3CSK4 on Anti-IgE Induced Human Mast Cell Activation
    Yu, Yangyang
    Yip, Kwok Ho
    Tam, Issan Yee San
    Sam, Sze Wing
    Ng, Chun Wai
    Zhang, Wei
    Lau, Hang Yung Alaster
    PLOS ONE, 2014, 9 (11):
  • [8] Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury
    Mersmann, Jan
    Berkels, Reinhard
    Zacharowski, Paula
    Tran, Nguyen
    Koch, Alexander
    Iekushi, Kazuma
    Dimmeler, Stefanie
    Granja, Tiago F.
    Boehm, Olaf
    Claycomb, William C.
    Zacharowski, Kai
    CRITICAL CARE MEDICINE, 2010, 38 (03) : 903 - 909
  • [9] Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis
    Song, Z.
    Deng, X.
    Chen, W.
    Xu, J.
    Chen, S.
    Zhong, H.
    Hao, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (11) : 2169 - 2176
  • [10] A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by Pam3CSK4, R-837 and CpG-2006 stimulation
    Mansson, Anne
    Adner, Mikael
    Hockerfelt, Ulf
    Cardell, Lars-Olaf
    IMMUNOLOGY, 2006, 118 (04) : 539 - 548